CHIORAZZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 23.575
AS - Asia 14.993
EU - Europa 10.791
SA - Sud America 1.806
Continente sconosciuto - Info sul continente non disponibili 1.530
AF - Africa 300
OC - Oceania 77
Totale 53.072
Nazione #
US - Stati Uniti d'America 22.273
SG - Singapore 5.076
CN - Cina 3.013
IT - Italia 2.992
VN - Vietnam 2.981
HK - Hong Kong 1.592
DE - Germania 1.564
RU - Federazione Russa 1.443
BR - Brasile 1.323
CA - Canada 1.064
SE - Svezia 1.052
IE - Irlanda 816
GB - Regno Unito 596
UA - Ucraina 573
FR - Francia 553
IN - India 441
BD - Bangladesh 296
KR - Corea 282
FI - Finlandia 252
ID - Indonesia 221
AT - Austria 189
AR - Argentina 173
JP - Giappone 167
TR - Turchia 166
NL - Olanda 142
IQ - Iraq 128
DK - Danimarca 121
ES - Italia 105
MX - Messico 101
ZA - Sudafrica 99
PK - Pakistan 94
PL - Polonia 85
LT - Lituania 75
EC - Ecuador 70
PH - Filippine 70
SA - Arabia Saudita 70
CO - Colombia 68
CH - Svizzera 67
VE - Venezuela 59
AU - Australia 56
MY - Malesia 56
BE - Belgio 55
IR - Iran 42
AE - Emirati Arabi Uniti 34
CL - Cile 32
EG - Egitto 32
MA - Marocco 32
PY - Paraguay 32
UZ - Uzbekistan 32
TN - Tunisia 29
ET - Etiopia 25
JO - Giordania 25
KE - Kenya 25
EU - Europa 23
TW - Taiwan 23
TH - Thailandia 22
HN - Honduras 21
KZ - Kazakistan 21
CR - Costa Rica 20
NP - Nepal 20
NZ - Nuova Zelanda 20
OM - Oman 20
JM - Giamaica 19
PE - Perù 19
AZ - Azerbaigian 18
CZ - Repubblica Ceca 15
UY - Uruguay 15
BO - Bolivia 14
IL - Israele 14
DZ - Algeria 13
HU - Ungheria 13
PS - Palestinian Territory 13
AL - Albania 12
NI - Nicaragua 12
PA - Panama 12
RO - Romania 12
TT - Trinidad e Tobago 12
BG - Bulgaria 10
NG - Nigeria 10
KG - Kirghizistan 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
HR - Croazia 7
SN - Senegal 7
AO - Angola 6
LB - Libano 6
MD - Moldavia 6
RS - Serbia 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
BB - Barbados 5
GR - Grecia 5
KW - Kuwait 5
LV - Lettonia 5
NO - Norvegia 5
CI - Costa d'Avorio 4
PR - Porto Rico 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 51.502
Città #
Singapore 3.152
Ann Arbor 2.860
Ashburn 2.141
San Jose 1.827
Dallas 1.592
Hong Kong 1.513
Milan 1.118
Ho Chi Minh City 875
Frankfurt am Main 816
Dublin 790
Woodbridge 774
Chandler 745
Toronto 710
Hanoi 692
Wilmington 649
Houston 625
Council Bluffs 594
New York 574
Fairfield 566
Jacksonville 557
Dearborn 547
Los Angeles 496
Santa Clara 463
Beijing 439
Chicago 328
Princeton 304
Boardman 297
Seattle 263
Hefei 252
The Dalles 251
Seoul 242
Nanjing 237
Rome 207
Columbus 197
Shanghai 179
Buffalo 178
Lauterbourg 167
Cambridge 163
Vienna 163
Jakarta 149
São Paulo 120
Guangzhou 110
Moscow 110
Orem 105
Helsinki 99
Da Nang 97
Dong Ket 92
Haiphong 92
Munich 92
Tokyo 92
Lachine 85
Phoenix 83
Lawrence 82
Montreal 78
Altamura 73
Chennai 73
Nanchang 73
Shenyang 73
Denver 67
Brooklyn 65
London 65
Hải Dương 63
Warsaw 59
Atlanta 58
Vilnius 58
Ha Long 57
Baghdad 55
Andover 52
Rio de Janeiro 52
Biên Hòa 50
Pune 50
Amsterdam 49
Carate Brianza 49
Zurich 49
Changsha 48
San Francisco 48
Stockholm 48
Hangzhou 47
Nuremberg 46
Jinan 45
San Diego 45
Can Tho 43
Falls Church 43
Johannesburg 43
Zhengzhou 43
Ottawa 42
Basingstoke 40
Ninh Bình 40
Quận Bình Thạnh 40
Washington 40
Fremont 39
Boston 38
Bắc Ninh 38
Florence 38
Jiaxing 38
Poplar 38
Springfield 38
Brussels 37
Tianjin 37
Turku 36
Totale 32.297
Nome #
CIPN and its mechanism of development 657
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 592
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 521
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 518
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 515
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 483
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 478
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 465
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 452
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 448
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 446
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 438
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 436
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 435
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 432
Age-related changes in the function and structure of the peripheral sensory pathway in mice 430
Artificial apolipoprotein corona enables nanoparticle brain targeting 422
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 416
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 414
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 411
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 406
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 398
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 397
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 396
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 392
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 392
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 383
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 371
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 367
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 355
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 355
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 353
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 348
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 343
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 342
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 341
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 340
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 337
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 337
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 334
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 333
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 331
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 327
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 326
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 326
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 319
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 319
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 317
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 317
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 317
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 313
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 312
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 311
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 310
OCT2 transporter involvement in development of cisplatin toxicity 309
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 307
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 304
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 303
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 301
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 300
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 297
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 292
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 291
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 291
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 289
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 288
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 288
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 287
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 285
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 283
Multimodal experimental approach to the study of human neurological diseases 283
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 282
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 281
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 280
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 279
MSCs effect on Dark Agouti rats affected by chronic EAE 279
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 279
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 278
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 275
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 274
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 274
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 273
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 273
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 272
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 269
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 268
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 267
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 266
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 266
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 265
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 265
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 263
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 263
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 263
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 263
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 261
Lipoplatin tm: a less neurotoxic formulation of cisplatin 260
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 260
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 259
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 258
Totale 33.987
Categoria #
all - tutte 160.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.560 0 0 171 177 139 181 95 106 82 143 134 332
2022/20233.423 389 830 372 325 249 529 63 179 272 51 103 61
2023/20242.946 95 97 97 143 386 712 501 163 156 68 68 460
2024/20257.844 447 891 711 363 617 292 508 280 891 1.028 662 1.154
2025/202622.326 2.949 1.858 2.441 1.768 1.942 1.266 2.841 1.061 1.702 1.743 1.310 1.445
2026/20273.083 953 906 1.224 0 0 0 0 0 0 0 0 0
Totale 53.072